Invests in
Locations:
Min Investment:
$685,000.00Max Investment:
$27,000,000.00Target Investment:
$14,000,000.00
Skills
Education
- C
Lists including Isabelle
Investments
Exo
Total Funding: $310M
MaaT Pharma
Total Funding: $20M
Karius
Total Funding: $330M
Inalve
Total Funding: $2M
Sinay
Total Funding: $5M
Graphite Innovation & Technologies
Total Funding: $7M
Clinical Microbiomics
Total Funding: $10M
Polaris
Total Funding: $6M
Abalos Therapeutics
Total Funding: $36M
Dopavision
Total Funding: $14M
Work Experience
2001
président du directoire / CEO
2014
In addition to the responsibility of heading the lifesciences team, and to the independent board member position at Comigel, Isabelle has been promoted as président du directoire / CEO in January 2014
lifesciences department director
2001
CEO / Directeur General
2011 - 2014
In addition to the responsibility of lifesciences, and to the independent board member position at Comigel, Isabelle has been promoted as CEO in October 2011
Président de la commission Capital Investissement
2019
As the president of the Capital Investment Commission for the French Asset Management Association (AFG), I am liaising with the French government and the French Financial Markets Authority (AMF) to improve the capital investment sector in France
2018 - 2021
Qualified personality for the French government "Conseil de l'innovation"
2018 - 2021
2015 - 2018
Board Member
2015 - 2018
2011 - 2018
Independent board member
2011 - 2018
as independent board member, the mission is to open my international network, share my experience of innovative fast growing companies, and bring strategic input, especially on nutrition and health fields
1998 - 2001
Associate Director of Business Devlopment Departement
1998 - 2001
1993 - 1998
Business Devpt Manager
1993 - 1998
1991 - 1993
Auditor
1991 - 1993
financial auditor